Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

Transcript of AGN’s 3Q17 CC:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 719
Posts 108,362
Boards Moderated 22
Alias Born 09/05/02
160x600 placeholder
FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab) PR Newswire (US) - 6/13/2019 7:13:00 PM
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar... PR Newswire (US) - 5/28/2019 7:30:00 AM
Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/24/2019 4:05:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/23/2019 4:18:09 PM
Allergan to Present at the Jefferies 2019 Healthcare Conference PR Newswire (US) - 5/23/2019 7:30:00 AM
Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis PR Newswire (US) - 5/17/2019 7:30:00 AM
Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/16/2019 7:30:00 AM
Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighti... PR Newswire (US) - 5/15/2019 7:30:00 AM
PatientFi® Announces Study Partnership with Allergan Business Wire - 5/15/2019 6:00:00 AM
Allergan to Present at the Bank of America Merrill Lynch 2019 Health Care Conference PR Newswire (US) - 5/9/2019 7:30:00 AM
Takeda Sells Eye Drug to Novartis -- WSJ Dow Jones News - 5/9/2019 3:02:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 5:29:05 PM
Allergan Reports First Quarter 2019 Financial Results PR Newswire (US) - 5/7/2019 7:00:00 AM
Medicines360 and Allergan Present Six-Year Clinical Data from Largest Ongoing Phase 3 Study of an Intrauterine System in the ... PR Newswire (US) - 5/6/2019 8:50:00 AM
Allergan Declares Second Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire (US) - 5/3/2019 7:45:00 AM
Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Re... PR Newswire (US) - 5/3/2019 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:52:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:51:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:49:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:46:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:46:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:43:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:41:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:40:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:39:40 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist